Treatment of cardiac shock by metaraminol.
D006801:Humans; D008616:Mephentermine / Q000627:therapeutic use*; D008680:Metaraminol; D009203:Myocardial Infarction / Q000150:complications*; D009638:Norepinephrine / Q000627:therapeutic use*; D012769:Shock / Q000209:etiology*; D012770:Shock, Cardiogenic; D013566:Sympathomimetics / Q000627:therapeutic use*
D013566:Sympathomimetics; D008680:Metaraminol; D008616:Mephentermine; D009638:Norepinephrine
ARTERENOL/therapeutic use; MEPHENTERMINE/therapeutic use; MYOCARDIAL INFARCT/complications; SHOCK/etiology and pathogenesis; SYMPATHOMIMETICS/therapeutic use
Am J Med. 1953 Sep;15(3):330-43
13080281
Circulation. 1953 Dec;8(6):883-92
13106909
Circulation. 1954 Jan;9(1):38-47
13116374
Circulation. 1954 Apr;9(4):527-32
13150516
Circulation. 1954 Jul;10(1):84-93
13172865
Circulation. 1954 Aug;10(2):265-70
13182760
Anesthesiology. 1954 Sep;15(5):547-50
13189164
Postgrad Med. 1954 Oct;16(4):287-96
13204241
Am J Med Sci. 1955 Oct;230(4):357-69
13258566
Circulation. 1956 Jun;13(6):834-6
13356437
Circ Res. 1956 Nov;4(6):653-8
13365070
Br Med J. 1958 Feb 1;1(5065):247-51
13499913
Am J Med. 1958 Jun;24(6):871-81
13533454
Am Heart J. 1955 Jul;50(1):136-44
14387943
Am Heart J. 1952 Sep;44(3):396-406
14952463
Am Heart J. 1952 Sep;44(3):407-27
14952464
Br J Pharmacol Chemother. 1949 Dec;4(4):373-80
15398550